Therapeutic Alliance Tensions and Repair in Psychotherapy Practices
1 other identifier
interventional
84
1 country
2
Brief Summary
This study evaluates a professional development program intended to improve the relationship or alliance between therapists and patients/clients who are receiving psychotherapy in the community. Half of the participating therapists will receive training to detect and improve alliance with new patients while half will not. The professional development training is expected to improve therapists effectiveness in identifying and correcting alliance tensions which will, in turn, improve therapeutic outcomes for patients/clients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2018
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2018
CompletedFirst Submitted
Initial submission to the registry
February 16, 2018
CompletedFirst Posted
Study publicly available on registry
March 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 14, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 14, 2021
CompletedMay 1, 2026
June 1, 2022
3.3 years
February 16, 2018
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean tension resolution rating scale
The Rupture Resolution Rating System (3RS) is an observer-based measure to identify alliance tensions and resolution processes. Independent blind reliable trained judges will rate video recordings of 6 psychotherapy session recorded with participating clients. A mean tension score will be assigned per client which will be the average of the 6 session scores. score ranges from 1 (withdrawal/confrontation rupture(s) did not occur; not significant for the alliance) to 5 (withdrawal/confrontation rupture(s) occurred; significant for the alliance).
6 therapy sessions over 6 weeks up to 6 months depending on the frequency of therapy
Secondary Outcomes (2)
Generalized Anxiety Disorder 7-item scale (GAD-7) change from baseline
baseline and end of 6 therapy sessions, 6 weeks to 6 months depending on the frequency of therapy
Patient Health Questionnaire 9-item scale (PHQ-9) change from baseline
baseline and end of 6 therapy sessions, 6 weeks to 6 months depending on the frequency of therapy
Study Arms (2)
Professional Development Program
EXPERIMENTALTherapists who participate in workshops and consultation sessions with study trainers during study-related therapy sessions and their participating patients/clients.
Control
NO INTERVENTIONTherapists who did not participate in workshops and consultations sessions while engaging in study-related therapy sessions and their participating patients/clients.
Interventions
Professional development program consists of training including workshops and consultation sessions to enhance therapists ability to detect and repair alliance ruptures in active community based psychotherapy.
Eligibility Criteria
You may qualify if:
- regulated health professional
- in good standing with a Canadian provincial regulatory college
- scope of practice includes psychotherapy
- ability to add 3 or more new, English speaking clients to caseload over 6 to 9 months
- ability to obtain timely permission to conduct research from therapist's employing institution or health group when applicable
You may not qualify if:
- none
- Patient/Client
- years of age or older
- will participate in psychotherapy sessions in English
- will see the study-affiliated therapist for a minimum of 6 sessions in the next 6 months
- already seeing another therapist
- diagnosed with a neurocognitive disorder
- diagnosed with a psychotic disorder
- expressed suicidal behaviour in the past six months as assessed by their participating therapist
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Ottawa
Ottawa, Ontario, K1N 6N5, Canada
Mt. Sinai Hospital
Toronto, Ontario, M5G 1X5, Canada
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Giorgio Tasca, Ph.D.
University of Ottawa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participating therapists will be aware of their group (Asynchronous virtual training, synchronous virtual workshop training, no training control); however, their participating patient/clients will not know which experimental group their therapists belongs to.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 16, 2018
First Posted
March 5, 2018
Study Start
February 1, 2018
Primary Completion
May 14, 2021
Study Completion
August 14, 2021
Last Updated
May 1, 2026
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share